The biotech Gilead Sciences has been the best-performing healthcare stock in the S&P 500 by far over the past 12 months. Its ...

Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the ...

It’s about what is possible when innovation meets intention,” Mary Ogangwu, chief Operating officer of Codix Bio, said at a press briefing in Lagos. Access to timely and accurate diagnostics remains a ...

The right-wing rag probably thought it dropped a bOmBsHeLL with its recent report on how the Biden Administration spent ...

A Rockdale County man is charged with intentionally infecting and subsequently killing his wife, Denise Broadie, with AIDS.

Gain key insights from Gilead Sciences' Q1 2025 earnings call, featuring strong HIV sales, Lenacapavir launch updates, and market trends shaping ...

Demonstrators gathered Thursday on the steps of the Department of Health and Human Services (HHS) building for a “die-in” ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

Looking ahead, Gilead Sciences cut its full-year earnings outlook to $5.65 to $6.05 a share from a prior range of $5.95 to $6.35 a share. Analysts had been expecting full-year earnings of $6.22. The ...

Sales of cancer drug Trodelvy fell 5% to $293 million, below analysts' estimates of $362 million, due to pricing and ...

In response to funding uncertainties under Trump policies, the Medical College has also capped Ph.D. admissions and ended ...

Streamer Johnny Somali could be looking at even more charges after making threats to spread STDs and inject one of his rivals with HIV.